NUWE Nuwellis, Inc. - Common Stock
NASDAQ · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 13, 2026
$0,69
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$0,12mínima 52 sem
$6,40máxima 52 sem
Capitalização de Mercado (MRQ)
$398.6K
P/E (TTM)
0.1
EPS (TTM)
$7.46
Receita (TTM)
$9M
seus distintivos
Intervalo 52 Semanas
$0–$6
Classificação do Analista
HOLD
Preço-Alvo
·
P/E
0.1
ROE
205.6%
Margem de Lucro Líquido
-125.6%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
NUWE Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.69
Capitalização de Mercado (MRQ)
$398.6K
P/E (TTM)
0.1
EPS (TTM)
$7.46
Receita (TTM)
$9M
ROE (TTM)
205.6%
Intervalo 52 Semanas
$0–$6
NUWE Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 26 de Junho de 2026 | 1-for-35 | Reverso |
| 7 de Julho de 2025 | 1-for-42 | Reverso |
| 28 de Junho de 2024 | 1-for-35 | Reverso |
| 12 de Dezembro de 2022 | 1-for-100 | Reverso |
| 19 de Outubro de 2020 | 1-for-30 | Reverso |
| 3 de Janeiro de 2019 | 1-for-14 | Reverso |
| 13 de Outubro de 2017 | 1-for-20 | Reverso |
| 13 de Janeiro de 2017 | 1-for-30 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$8M2016-12-31 → 2025-12-31
EPS$-25.392020-12-31 → 2025-12-31
Fluxo de caixa livre$-11M2016-12-31 → 2025-12-31
Margem líquida-125.6%2017-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | NUWE | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 0.1média 5A ≈-155.7 | ≈-155.7 | · | · | |
| P/S (TTM) | 0.0média 5A ≈44899.5 | ≈44899.5 | 18.7 | Subvalorizado | |
| P/B (MRQ) | -0.2média 5A ≈14078.9 | ≈14078.9 | · | · | |
| Preço / FCF (TTM) | -0.0média 5A ≈-19682.3 | ≈-19682.3 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -0.0média 5A ≈-19922.6 | ≈-19922.6 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | -0.2média 5A ≈14078.9 | ≈14078.9 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | NUWE | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 69.7%média 5A ≈59.1% | ≈59.1% | · | · | |
| Margem Operacional (TTM) | -142.9%média 5A ≈-181.3% | ≈-181.3% | -1756.6% | Primeira linha | |
| EBITDA Margin (Margem EBITDA) | -134.3%média 5A ≈-179.2% | ≈-179.2% | -1636.9% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | -125.6%média 5A ≈-196.9% | ≈-196.9% | · | · | |
| Margem de Lucro Líquido (TTM) | -125.6%média 5A ≈-197.0% | ≈-197.0% | -118.9% | Fraco | |
| ROA (TTM) | -123.6%média 5A ≈-116.1% | ≈-116.1% | -120.2% | Fraco | |
| ROE (TTM) | 205.6%média 5A ≈-46.1% | ≈-46.1% | -78.1% | Primeira linha | |
| ROIC | -423.4%média 5A ≈-279.2% | ≈-279.2% | · | · |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | NUWE | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 2.0média 5A ≈4.2 | ≈4.2 | 1.4 | Liquidez forte | |
| Quick Ratio (Índice de Liquidez Seca) | 0.9média 5A ≈3.4 | ≈3.4 | 0.8 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | NUWE | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -5.4%média 5A ≈2.3% | ≈2.3% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -1.1%média 5A ≈2.8% | ≈2.8% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 2.1% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | NUWE | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 1.0média 5A ≈0.6 | ≈0.6 | 0.3 | Primeira linha | |
| Inventory Turnover (Giro de Estoque) | 1.7média 5A ≈1.5 | ≈1.5 | 1.1 | Primeira linha | |
| Receivables Turnover (Giro de Contas a Receber) | 5.1média 5A ≈6.5 | ≈6.5 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$217.6K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-539.9%
Próximo relatório
Nov 10, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 13, 2026 | $-26.64 | $-0.69 | -3740.8% |
| 31 de Março de 2026 | Mai 11, 2026 | $-73.15 | $-35.70 | -104.9% |
| 31 de Dezembro de 2025 | $-52.50 | $-55.69 | 5.7% | |
| 31 de Março de 2025 | $-1014.30 | $-1139.54 | 11.0% | |
| 31 de Dezembro de 2024 | $-1029.00 | $-644.74 | -59.6% | |
| 30 de Setembro de 2024 | $73.08 | $-54.84 | 233.3% | |
| 30 de Junho de 2024 | $-791.70 | $-353.22 | -124.1% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $9M | $9M | $9M | $8M | $7M | $6M | $5M | $4M | $1M | $59.0K | $295.0K | |
| Cost of Revenue | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $713.0K | · | · | |
| Gross Profit | $5M | $6M | $5M | $5M | $4M | $4M | · | · | · | · | · | · | |
| R&D Expense | $3M | $3M | $5M | $4M | $5M | $4M | $5M | $3M | $1M | $8M | $18M | $17M | |
| SG&A Expense | $14M | $13M | $17M | $18M | $19M | $17M | $16M | $15M | $10M | $8M | $8M | $9M | |
| Operating Expenses | $16M | $17M | $23M | $22M | $24M | $21M | $24M | $22M | $18M | $17M | $26M | $26M | |
| Operating Income | $-11M | $-11M | $-18M | $-17M | $-20M | $-17M | $-18M | $-17M | $-15M | $-16M | $-26M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $504.0K | $743.0K | · | |
| Other Non-op | $10.0K | $-80.0K | $154.0K | $75.0K | $-19.0K | $-1.0K | $0 | $10.0K | $1M | $-184.0K | $-749.0K | $-49.0K | |
| Pretax Income | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | $-27M | $-26M | |
| Income Tax | $5.0K | $5.0K | $8.0K | $9.0K | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $-54.0K | $-124.0K | $-249.0K | |
| Net Income | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | · | · | |
| EPS (Basic) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · | |
| EPS (Diluted) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · | |
| Shares (Basic) | 690,145 | 31,601 | 56,126 | 173,846 | 69,000 | 1,649,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 690,145 | 31,601 | 56,126 | 173,846 | 69,000 | 1,649,000 | · | · | · | · | · | · | |
| EBITDA | $-11M | $-11M | $-18M | $-17M | $-19M | $-17M | $-18M | $-17M | $-14M | $-15M | $-26M | $-26M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $5M | $4M | $18M | $9M | $14M | $1M | $5M | $16M | $1M | $23M | $31M | |
| Receivables | $1M | $2M | $2M | $1M | $750.0K | $905.0K | $799.0K | $786.0K | $545.0K | $282.0K | · | $59.0K | |
| Inventory | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $677.0K | · | · | |
| Other Current Assets | $698.0K | $315.0K | $461.0K | $396.0K | $328.0K | $237.0K | $161.0K | $203.0K | $136.0K | $137.0K | $479.0K | $360.0K | |
| Current Assets | $5M | $9M | $8M | $23M | $28M | $19M | $4M | $8M | $18M | $2M | $24M | $32M | |
| PP&E (Net) | $368.0K | $478.0K | $728.0K | $980.0K | $1M | $1M | $991.0K | $536.0K | $570.0K | $540.0K | $535.0K | $661.0K | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $1M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $785.0K | |
| Goodwill | · | · | · | · | · | · | · | · | $0 | $189.0K | · | · | |
| Intangibles | $0 | · | · | · | · | · | · | · | $0 | $4M | · | · | |
| Other Non-current Assets | $271.0K | $21.0K | $120.0K | $21.0K | $21.0K | · | · | · | · | · | · | · | |
| Total Assets | $6M | $10M | $10M | $25M | $30M | $20M | $6M | $9M | $18M | $7M | $24M | $32M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $862.0K | $2M | $3M | $2M | |
| Current Liabilities | $3M | $3M | $3M | $5M | $3M | $4M | $3M | $3M | $2M | $3M | $8M | $3M | |
| Capital Leases | $67.0K | $307.0K | $544.0K | $760.0K | $956.0K | $55.0K | $261.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $179.0K | $0 | · | $0 | $126.0K | $126.0K | $400.0K | · | |
| Total Liabilities | $3M | $3M | $7M | $12M | $4M | $4M | $4M | $3M | $2M | $5M | $12M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Paid-in Capital | $319M | $305M | $291M | $280M | $279M | $250M | $218M | $204M | $197M | $169M | · | · | |
| Retained Earnings | $-316M | $-299M | $-288M | $-267M | $-253M | $-233M | $-218M | $-199M | $-182M | $-169M | $-153M | $-127M | |
| Stockholders' Equity | $3M | $7M | $3M | $12M | $26M | $16M | $2M | $6M | $16M | $2M | $12M | $29M | |
| Liabilities + Equity | $6M | $10M | $10M | $25M | $30M | $20M | $6M | $9M | $18M | $7M | $24M | $32M | |
| Shares Outstanding | 48,112 | 104,142 | 161,925 | 536,394 | 105,376 | 2,736,060 | 155,802 | 513,445 | 271,357 | 38,862 | 611,483 | 16,982,642 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $310.0K | $362.0K | $372.0K | $488.0K | $376.0K | $239.0K | $232.0K | $769.0K | $697.0K | $325.0K | $277.0K | |
| Stock-based Comp | $127.0K | $478.0K | $670.0K | $862.0K | $1M | $1M | $2M | $2M | $499.0K | $949.0K | $2M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $540.0K | $278.0K | $0 | · | |
| Other Non-cash | · | · | · | $-2M | $-104.0K | $-2M | $-4.0K | $153.0K | $194.0K | · | · | · | |
| Operating Cash Flow | $-11M | $-10M | $-18M | $-15M | $-18M | $-17M | $-16M | $-15M | $-12M | $-16M | $-23M | $-23M | |
| CapEx | $90.0K | $60.0K | $149.0K | $122.0K | $219.0K | $298.0K | $490.0K | $198.0K | $259.0K | $117.0K | $199.0K | $351.0K | |
| Investing Cash Flow | $-90.0K | $-60.0K | $330.0K | $15M | $-16M | $-267.0K | $-490.0K | $-198.0K | $-259.0K | $-4M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $8M | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Issued | $4M | $2M | · | · | · | · | · | · | · | · | $7M | $89.0K | |
| Net Stock Activity | $4M | · | · | · | · | · | · | · | · | · | $7M | $89.0K | |
| Financing Cash Flow | $7M | $11M | $4M | $9M | $28M | $30M | $13M | $5M | $26M | $-1M | · | · | |
| Net Change in Cash | $-4M | $1M | $-14M | $9M | $-6M | $13M | $-4M | $-10M | $14M | $-22M | $-8M | $-23M | |
| Taxes Paid | $7.0K | $7.0K | $12.0K | $9.0K | $11.0K | $10.0K | $4.0K | $2.0K | $6.0K | $47.0K | · | · | |
| Free Cash Flow | $-11M | $-10M | $-18M | $-15M | $-18M | $-17M | $-17M | $-15M | $-12M | $-16M | $-23M | $-23M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-17M | $-24M | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.0% | 64.9% | 56.2% | 55.7% | 56.7% | · | · | · | · | · | · | · | |
| Operating Margin | -134.3% | -125.7% | -198.9% | -201.0% | -246.5% | -228.8% | -328.5% | -340.9% | -416.9% | -1215.0% | -43996.6% | -8741.4% | |
| Net Margin | -211.9% | -127.8% | -228.0% | -170.0% | -247.2% | -212.8% | -328.7% | -340.8% | -376.6% | · | · | · | |
| Pretax Margin | -211.8% | -127.7% | -227.9% | -169.9% | -247.0% | -212.7% | -328.5% | -340.7% | -376.5% | -1229.3% | -45266.1% | -8758.0% | |
| EBITDA Margin | -134.3% | -125.7% | -198.9% | -196.6% | -240.4% | -223.8% | -324.2% | -336.2% | -395.2% | -1161.0% | -43445.8% | -8647.5% | |
| ROA | -219.3% | -113.7% | -117.3% | -52.7% | -77.6% | -123.6% | -252.0% | -125.1% | -103.2% | · | · | · | |
| ROE | 553.1% | -230.1% | -373.2% | -110.1% | -70.0% | -86.4% | -572.5% | -218.5% | -148.7% | · | · | · | |
| ROIC | -423.4% | -168.4% | -589.9% | -139.0% | -75.3% | -104.4% | -910.2% | -287.1% | -91.3% | -888.4% | -161.2% | -87.4% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.5 | 2.6 | 4.9 | 8.5 | 5.2 | 1.2 | 2.9 | 8.5 | 0.7 | 2.9 | 10.0 | |
| Quick Ratio | 0.9 | 2.7 | 1.8 | 4.1 | 7.5 | 4.3 | 0.6 | 2.2 | 7.7 | 0.5 | 2.9 | 9.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.3 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -31.1 | -34.9 | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.9 | 0.5 | 0.3 | 0.3 | 0.6 | 0.8 | 0.4 | 0.3 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | 1.7 | 1.6 | 1.7 | 1.4 | 1.2 | 1.4 | 1.5 | 2.3 | 2.4 | 2.1 | · | · | |
| Receivables Turnover | 5.1 | 4.8 | 5.3 | 7.9 | 9.6 | 8.7 | 7.0 | 7.5 | 8.6 | 7.6 | · | 5.0 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.56 | $1.49 | $0.53 | $23.04 | $2.46 | $5.96 | $0.43 | $11.56 | $4.27 | $2.26 | $0.66 | $1.72 | |
| Revenue / Share | $11.98 | $6.58 | $4.51 | $49.10 | $1.16 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-15.66 | $-7.23 | $-9.13 | $-87.06 | $-2.61 | · | · | · | · | · | · | · | |
| Cash / Share | $0.64 | $1.16 | $0.67 | $33.07 | $2.30 | $5.28 | $0.27 | $10.67 | $4.11 | $1.70 | $1.26 | $1.84 | |
| EPS (TTM) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.4% | -1.4% | 3.8% | 7.8% | 6.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.1% | 3.3% | 6.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $9M | $9M | $9M | $8M | $7M | $6M | $5M | $4M | $1M | $59.0K | $295.0K | |
| Net Income TTM | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | · | · | |
| Market Cap | $3M | $204M | $4.84B | $8.45B | $1.77T | $2.80T | $17.73T | $15.53T | · | · | · | · | |
| P/E | -0.1 | -0.1 | -2.4 | -188.6 | -587.3 | -96025.3 | · | · | · | · | · | · | |
| P/S | 0.4 | 23.3 | 546.6 | 989.4 | 222938.0 | 376742.3 | 3216634.1 | 3107852.4 | · | · | · | · | |
| P/B | 1.1 | 31.2 | 1620.4 | 684.0 | 68057.7 | 171794.3 | 8907975.0 | 2616753.1 | · | · | · | · | |
| P / Tangible Book | 1.1 | 31.2 | 1620.4 | 684.0 | 68057.7 | 171794.3 | · | · | · | · | · | · | |
| P / Cash Flow | -0.3 | -21.3 | -270.1 | -558.0 | -98763.5 | -169161.2 | -1083086.1 | -1066830.1 | · | · | · | · | |
| P / FCF | -0.3 | -21.1 | -267.9 | -553.5 | -97568.5 | -166173.1 | -1051602.9 | -1052517.0 | · | · | · | · | |
| Earnings Yield | -1459.2% | -757.8% | -42.2% | -0.53% | -0.17% | 0.00% | · | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Cost of Revenue | $471.0K | $719.0K | $770.0K | $772.0K | $767.0K | $837.0K | $967.0K | $711.0K | $720.0K | $666.0K | $1M | $1M | $928.0K | $759.0K | $1M | $806.0K | |
| Gross Profit | $1M | $2M | $2M | $1M | $958.0K | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| R&D Expense | $942.0K | $2M | $884.0K | $603.0K | $675.0K | $550.0K | $831.0K | $486.0K | $558.0K | $1M | $1M | $1M | $2M | $1M | $1M | $928.0K | |
| SG&A Expense | $4M | $5M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $5M | $4M | $3M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $6M | $5M | $5M | $6M | $7M | $6M | $5M | |
| Operating Income | $-3M | $-5M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-5M | $-4M | $-3M | $-5M | $-6M | $-5M | $-4M | |
| Other Non-op | $7.0K | $1.0K | $-11.0K | $4.0K | $10.0K | $7.0K | $7.0K | $8.0K | $6.0K | $-101.0K | $56.0K | $-204.0K | $179.0K | $123.0K | · | $52.0K | |
| Pretax Income | $-5M | $-5M | $-2M | $468.0K | $-13M | $-3M | $-1M | $2M | $-8M | $-4M | $-6M | $-3M | $-5M | $-6M | $-2M | $-4M | |
| Income Tax | $0 | $0 | $0 | $0 | $4.0K | $1.0K | $1.0K | $0 | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | |
| Net Income | $-5M | $-5M | $-2M | $468.0K | $-13M | $-3M | $-1M | $2M | $-8M | $-4M | $-6M | $-3M | $-5M | $-6M | $-2M | $-4M | |
| EPS (Basic) | $-26.64 | $-2.19 | $35.73 | $0.56 | $-2134.19 | $-28.93 | $389.40 | $73.23 | $-791.82 | $-24.11 | $-163.38 | $-63.27 | $-127.65 | $-5.76 | $36.29 | $-36.72 | |
| EPS (Diluted) | $-26.64 | $-2.19 | $35.73 | $0.56 | $-2134.19 | $-28.93 | $389.40 | $73.23 | $-791.82 | $-24.11 | $-163.38 | $-63.27 | $-127.65 | $-5.76 | $36.29 | $-36.72 | |
| Shares (Basic) | 181,243 | 2,074,940 | · | 836,386 | 5,881 | 104,142 | · | 204,710 | 9,755 | 179,608 | · | 53,265 | 37,949 | 1,125,993 | · | 105,000 | |
| Shares (Diluted) | 181,243 | 2,074,940 | · | 836,386 | 5,881 | 104,142 | · | 204,710 | 9,755 | 179,608 | · | 53,265 | 37,949 | 1,125,993 | · | 105,000 | |
| EBITDA | $-3M | $-5M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-5M | · | $-3M | $-5M | $-6M | · | $-4M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $2M | $1M | $3M | $4M | $3M | $5M | $2M | $1M | $1M | $4M | $5M | $9M | $12M | $18M | $12M | |
| Receivables | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| Other Current Assets | $690.0K | $406.0K | $698.0K | $776.0K | $745.0K | $274.0K | $315.0K | $430.0K | $544.0K | $440.0K | $461.0K | $947.0K | $943.0K | $477.0K | $396.0K | $368.0K | |
| Current Assets | $8M | $6M | $5M | $7M | $8M | $6M | $9M | $5M | $5M | $5M | $8M | $10M | $14M | $17M | $23M | $16M | |
| PP&E (Net) | $347.0K | $365.0K | $368.0K | $414.0K | $359.0K | $405.0K | $478.0K | $551.0K | $630.0K | $681.0K | $728.0K | $912.0K | $875.0K | $907.0K | $980.0K | $1M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | $4M | · | · | · | $4M | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | · | $3M | · | |
| Intangibles | $102.0K | $112.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $599.0K | $420.0K | $271.0K | $21.0K | $21.0K | $21.0K | $21.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $106.0K | $21.0K | $21.0K | |
| Total Assets | $9M | $7M | $6M | $8M | $9M | $7M | $10M | $7M | $6M | $7M | $10M | $11M | $16M | $18M | $25M | $18M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Current Liabilities | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $0 | $67.0K | $128.0K | $189.0K | $249.0K | $307.0K | $368.0K | $428.0K | $488.0K | $544.0K | $601.0K | $654.0K | $708.0K | $760.0K | $810.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Liabilities | $11M | $4M | $3M | $4M | $18M | $3M | $3M | $4M | $13M | $6M | $7M | $4M | $4M | $5M | $12M | $4M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $0 | $0 | $0 | $0 | $0 | $1.0K | |
| Paid-in Capital | $324M | $324M | $319M | $318M | $305M | $305M | $305M | $301M | $293M | $293M | $291M | $290M | $290M | $288M | $280M | $280M | |
| Retained Earnings | $-326M | $-321M | $-316M | $-314M | $-314M | $-302M | $-299M | $-297M | $-300M | $-292M | $-288M | $-282M | $-279M | $-274M | $-267M | $-266M | |
| Stockholders' Equity | $-2M | $3M | $3M | $4M | $-9M | $4M | $7M | $3M | $-7M | $885.0K | $3M | $8M | $11M | $14M | $12M | $14M | |
| Liabilities + Equity | $9M | $7M | $6M | $8M | $9M | $7M | $10M | $7M | $6M | $7M | $10M | $11M | $16M | $18M | $25M | $18M | |
| Shares Outstanding | 574,455 | 2,635,718 | 1,686,217 | 1,364,970 | 527,158 | 4,373,968 | 104,142 | 1,866,890 | 515,744 | 6,801,443 | 161,925 | 1,864,265 | 1,864,265 | 1,206,932 | 536,394 | 10,537,606 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $37.0K | $38.0K | $34.0K | $43.0K | $50.0K | $73.0K | $83.0K | $76.0K | $75.0K | $76.0K | $109.0K | $84.0K | $83.0K | $86.0K | · | $95.0K | |
| Stock-based Comp | $22.0K | $25.0K | $24.0K | $19.0K | $17.0K | $67.0K | $104.0K | $101.0K | $115.0K | $158.0K | $157.0K | $135.0K | $197.0K | $181.0K | $165.0K | $220.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $112.0K | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M | $-6M | $-3M | $-3M | |
| CapEx | $9.0K | $30.0K | $-12.0K | $98.0K | $4.0K | $0 | $23.0K | $-16.0K | $24.0K | $29.0K | $-36.0K | $121.0K | $51.0K | $13.0K | $19.0K | $22.0K | |
| Investing Cash Flow | $-9.0K | $-284.0K | $12.0K | $-98.0K | $-4.0K | $0 | $-23.0K | $16.0K | $-24.0K | $-29.0K | $36.0K | $-121.0K | $513.0K | $-98.0K | $15M | $-22.0K | |
| Stock Issued | · | $4M | $0 | $0 | $4M | $0 | $0 | $0 | · | · | · | $-2M | · | · | · | $0 | |
| Net Stock Activity | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $4M | $1M | $2M | $4M | $0 | $5M | $3M | $2M | $500.0K | $2M | $-20.0K | $2M | $-11.0K | $9M | $-15.0K | |
| Net Change in Cash | $2M | $999.0K | $-2M | $-1M | $2M | $-3M | $3M | $884.0K | $-377.0K | $-2M | $-1M | $-4M | $-3M | $-6M | $21M | $-3M | |
| Free Cash Flow | · | $-3M | · | · | · | $-3M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.1% | 70.1% | · | 65.2% | 55.5% | 56.0% | · | 70.0% | 67.2% | 64.1% | · | 57.3% | 55.3% | 58.4% | · | 61.0% | |
| Operating Margin | -160.9% | -190.1% | · | -121.6% | -168.5% | -160.7% | · | -64.7% | -105.7% | -255.7% | · | -131.2% | -242.0% | -320.4% | · | -189.8% | |
| Net Margin | -245.2% | -189.0% | · | 21.1% | -727.7% | -158.3% | · | 99.6% | -352.1% | -233.2% | · | -139.7% | -233.5% | -355.1% | · | -187.4% | |
| Pretax Margin | -245.2% | -189.0% | · | 21.1% | -727.5% | -158.2% | · | 99.6% | -352.0% | -233.1% | · | -139.6% | -233.4% | -355.0% | · | -187.3% | |
| EBITDA Margin | -160.9% | -190.1% | · | -121.6% | -168.5% | -160.7% | · | -64.7% | -105.7% | -255.7% | · | -131.2% | -242.0% | -315.7% | · | -189.8% | |
| ROA | -52.7% | -65.0% | · | 6.4% | -163.1% | -44.1% | · | 26.0% | -71.1% | -34.4% | · | -22.6% | -25.8% | -29.1% | · | -14.7% | |
| ROE | 87.7% | -145.6% | · | 13.2% | 158.9% | -135.1% | · | 42.8% | -364.6% | -59.5% | · | -30.8% | -33.7% | -36.7% | · | -17.6% | |
| ROIC | 154.2% | -171.7% | · | -69.0% | 32.4% | -85.5% | · | -48.2% | 34.0% | -536.9% | · | -40.4% | -45.4% | -42.8% | · | -28.0% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.6 | · | 2.0 | 2.2 | 2.2 | · | 2.0 | 1.2 | 1.2 | · | 3.2 | 3.6 | 4.0 | · | 4.6 | |
| Quick Ratio | 1.4 | 1.0 | · | 1.2 | 1.4 | 1.5 | · | 1.2 | 0.6 | 0.6 | · | 2.1 | 2.6 | 3.1 | · | 3.6 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.4 | 1.6 | · | 1.8 | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.5 | · | 1.9 | 1.7 | 1.6 | · | 1.9 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.58 | $1.01 | · | $2.86 | $-17.00 | $0.82 | · | $1.70 | $-13.25 | $0.13 | · | $4.20 | $5.94 | $11.32 | · | $1.33 | |
| Revenue / Share | $10.86 | $1.16 | · | $2.65 | $8.38 | $0.44 | · | $1.75 | $5.36 | $0.30 | · | $1.29 | $1.56 | $1.62 | · | $0.20 | |
| Cash Flow / Share | · | $-1.50 | · | · | · | $-0.58 | · | · | · | $-0.46 | · | · | · | $-5.42 | · | · | |
| Cash / Share | $6.83 | $0.79 | · | $2.27 | $8.44 | $0.58 | · | $1.02 | $1.98 | $0.21 | · | $2.64 | $4.77 | $9.54 | · | $1.14 | |
| EPS (TTM) | $7.46 | $-2100.09 | · | $-1773.16 | $-1700.49 | $-358.12 | · | $-906.08 | $-1042.58 | $-378.41 | · | $-160.39 | $-133.84 | $-46.86 | · | $-402.11 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $9M | · | $8M | $8M | $9M | · | $9M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Net Income TTM | $-11M | $-19M | · | $-17M | $-15M | $-10M | · | $-15M | $-21M | $-18M | · | $-17M | $-17M | $-17M | · | $-17M | |
| Market Cap | $2M | $3M | · | $5M | $5M | $173M | · | $93M | $109M | $3.60B | · | $3.92B | $7.37B | $8.62B | · | $836.48B | |
| P/E | 0.4 | -0.0 | · | -0.0 | -0.0 | -0.1 | · | -0.1 | -0.2 | -1.4 | · | -13.1 | -29.5 | -152.5 | · | -197.4 | |
| P/S | 0.2 | 0.3 | · | 0.6 | 0.6 | 19.7 | · | 10.4 | 12.1 | 404.6 | · | 452.9 | 887.6 | 1021.3 | · | 106611.7 | |
| P/B | -0.9 | 1.0 | · | 1.2 | -0.5 | 48.3 | · | 29.4 | -15.9 | 4067.0 | · | 499.9 | 665.7 | 631.0 | · | 59680.0 | |
| P / Tangible Book | · | 1.1 | · | 1.2 | · | 48.3 | · | 29.4 | · | 4067.0 | · | 499.9 | 665.7 | 631.0 | · | 59680.0 | |
| P / Cash Flow | · | -0.9 | · | · | · | -68.1 | · | · | · | -1257.6 | · | · | · | -1412.1 | · | · | |
| Earnings Yield | 244.6% | -200008.6% | · | -52930.2% | -18403.6% | -907.1% | · | -1812.9% | -493.5% | -71.5% | · | -7.6% | -3.4% | -0.66% | · | -0.51% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $8M | $9M | $9M | $9M | $8M |
| Margem Bruta % | 62.0% | 64.9% | 56.2% | 55.7% | 56.7% |
| Margem Operacional % | -134.3% | -125.7% | -198.9% | -201.0% | -246.5% |
| Lucro líquido | $-18M | $-11M | $-20M | $-15M | $-20M |
| EPS Diluído | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.7 | 3.5 | 2.6 | 4.9 | 8.5 |
| Índice de Liquidez Seca | 0.9 | 2.7 | 1.8 | 4.1 | 7.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-11M | $-10M | $-18M | $-15M | $-18M |
Investidores institucionais (13F)
Atividade institucional — Q1 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 2 (-1 vs trimestre anterior) | 3 (+3 vs trimestre anterior) | 3 (0 vs trimestre anterior) | 1 (-1 vs trimestre anterior) | +178K |
Comparado a Q4 2025. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| ERB JOHN L | 16 de Junho de 2025 | 7,30% | Declaração inicial | Investimento passivo | SEC |
| Ki Yong Choi IRS Identification Nos. of Above Persons (Entities Only) ×5 declarações | 20 de Setembro de 2017 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 35 insiders · 20 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| ERB JOHN L | CEO and President | 27 de Junho de 2025 A | 1.100.022 | 0 | 0 | $0 |
| Nestor Jaramillo Jr. | President and CEO | 15 de Março de 2023 P | 4.098 | 0 | 0 | $0 |
| David A Rosa | Chief Executive Officer | 1 de Agosto de 2015 F | 119.587 | 0 | 0 | $0 |
| Robert Benjamin Scott | Chief Financial Officer | 2 de Setembro de 2023 A | · | 0 | 0 | $0 |
| Lynn Larson Blake | Chief Financial Officer | 6 de Janeiro de 2023 A | · | 0 | 0 | $0 |
| George Montague | CFO and Treasurer | 3 de Março de 2022 A | · | 0 | 0 | $0 |
| Claudia Drayton | Chief Financial Officer | 22 de Janeiro de 2021 A | 740 | 0 | 0 | $0 |
| Jeffrey S Mathiesen | Chief Financial Officer | 1 de Janeiro de 2015 F | 37.223 | 0 | 0 | $0 |
| AYOTTE NEIL P | SVP, Secretary, GC & CCO | 3 de Março de 2023 A | · | 0 | 0 | $0 |
| Thomas P. Lynch | Chief Legal Compliance Officer | 22 de Janeiro de 2021 A | · | 0 | 0 | $0 |
| Jim Breidenstein | Chief Commercial Officer | 3 de Janeiro de 2018 A | · | 0 | 0 | $0 |
| Molly Wade | Vice President | 15 de Janeiro de 2017 F | 909 | 0 | 0 | $0 |
| Eric Lovett | VP, Clinical Affairs | 14 de Janeiro de 2016 A | · | 0 | 0 | $0 |
| Brian Brown | SVP, Technology & Operations | 13 de Agosto de 2015 P | 20.000 | 0 | 0 | $0 |
| Debra Kridner | Exec VP, Regulatory Affairs | 11 de Agosto de 2015 P | 29.500 | 0 | 0 | $0 |
| Kimberly Oleson | SVP, Clinical Affairs | 1 de Junho de 2015 F | 3.810 | 0 | 0 | $0 |
| William S Peters | CTO & Medical Director | 1 de Janeiro de 2015 F | 33.309 | 0 | 0 | $0 |
| Jim Yearick | VP of Marketing and Sales | 8 de Maio de 2014 F | 10.153 | 0 | 0 | $0 |
| Kevin Bassett | Senior VP, Tech & Operations | 8 de Maio de 2014 F | 10.426 | 0 | 0 | $0 |
| Patrick Verta | Chief Medical Officer | 21 de Outubro de 2013 A | · | 0 | 0 | $0 |
| Archelle Georgiou Feldshon | Conselheiro | 28 de Abril de 2026 A | · | 0 | 0 | $0 |
| David Mcdonald | Conselheiro | 28 de Abril de 2026 A | · | 0 | 0 | $0 |
| Martin J Emerson | Conselheiro | 28 de Abril de 2026 A | · | 0 | 0 | $0 |
| Gregory D Waller | Conselheiro | 28 de Abril de 2026 A | 2 | 0 | 0 | $0 |
| Michael Kendrick Mccormick | Conselheiro | 20 de Maio de 2025 A | · | 0 | 0 | $0 |
| Jon W Salveson | Conselheiro | 19 de Maio de 2023 A | 42.492 | 0 | 0 | $0 |
| WATSON WARREN S | Conselheiro | 19 de Maio de 2023 A | 42.492 | 0 | 0 | $0 |
| Steven Frank Brandt | Conselheiro | 25 de Maio de 2022 A | 1.437 | 0 | 0 | $0 |
| Maria Rosa Costanzo | Conselheiro | 3 de Setembro de 2019 J | · | 0 | 0 | $0 |
| Matthew E. Likens | Conselheiro | 23 de Maio de 2019 A | 1.437 | 0 | 0 | $0 |
| Paul Buckman | Conselheiro | 26 de Maio de 2016 A | 56.876 | 0 | 0 | $0 |
| Geoffrey Brooke | Conselheiro | 29 de Maio de 2014 A | 7.855 | 0 | 0 | $0 |
| Nicholas Callinan | Conselheiro | 14 de Setembro de 2012 P | 32.147 | 0 | 0 | $0 |
| Donal O'Dwyer | Conselheiro | 17 de Agosto de 2012 P | 52.466 | 0 | 0 | $0 |
| Choi Ki Yong | Detentor de 10% | 12 de Outubro de 2017 P | 1.793.109 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
NUWE Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 6 analistas
VENDA
0 0,0%
Compra forte
0 0,0%
Compra
3 50,0%
Manter
1 16,7%
Venda
2 33,3%
Venda forte
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 13, 2026